Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Study Comparing Discontinuation Symptoms in subjects with Major Depressive Disorder treated
for 24 Weeks with Open-label 50 mg Desvenlafaxine Succinate Sustained-Release Formulation
(DVS SR)